medigraphic.com
Instituto Nacional de Salud Pública

2012, Number 6

<< Back Next >>

salud publica mex 2012; 54 (6)

Neurocysticercosis is still prevalent in Mexico

Fleury A, Sciutto E, Larralde C

Language: English
References: 33
Page: 632-636
PDF size: 89.52 Kb.


ABSTRACT

In this work, we report the published cases of human and porcine cysticercosis, as well as Taenia solium taeniasis diagnosed in Mexico during the last 10 years. Numerical data allow us to state that this disease remains as a public health problem in our country. Whereas efficient tools have been developed for the diagnosis and prevention of cysticercosis, we strongly recommend further measures allowing the control and eventual eradication of this parasite in Mexico.


REFERENCES

  1. Sotelo J. Clinical manifestations, diagnosis, and treatment of neurocysticercosis. Curr Neurol Neurosci Rep 2011;11:529-535.

  2. Cohn-Zurita F, Guinto-Balanzar G, Pérez-Cerdán H. Neurocysticercosis associated with pituitary adenoma. Case report and literature review. Cir Cir. 2006;74:47-49.

  3. Chavarría A, Fleury A, Bobes RJ, Morales J, Fragoso G, Sciutto E. A depressed peripheral cellular immune response is related to symptomatic neurocysticercosis. Microbes Infect 2006;8:1082-1089.

  4. Ortiz-Trejo JM, Correa-Chacón AJ, Sctelo-Ham EI, Torres-Valenzuela A, Alvarado-Esquivel C. Risk factors associated with neurocysticercosis in a public hospital in Mexico. Gac Med Mex 2006;142:175-179.

  5. Alvarado-Esquivel C, Arreola-Valenzuela MA, Rodríguez-Briones A, Alanís-Quiñones OP, Estrada-Martínez S, Luevanos-Becerra C, et al. Seroprevalence of selected viral, bacterial and parasitic infections among inpatients of a public psychiatric hospital of Mexico. Rev Inst Med Trop Sao Paulo 2008;50:161-164.

  6. Jimenez-Vazquez OH, Nagore N. Cisternal neurocysticercosis. Br J Neurosurg 2008;22:774-775.

  7. Jimenez-Vazquez OH, Nagore N. Role of neuroendoscopy in the treatment of large viable cysticerci in the brain parenchyma. Br J Neurosurg 2008;22:682-683.

  8. Río de la Loza LJ, Meza EL. Cysticercotic encephalitis: case report of miliary infestation in an encephalopathic fashion. Arch Neurol 2008;65:276-277.

  9. Góngora-Rivera F, Soto-Hernández JL, Guevara P, Sotelo-Morales J. In neurocysticercosis, CSF cytokines correlate with cerebral blood flow velocities. Neurology 2008;71:1119-1122.

  10. Torres-Corzo JG, Tapia-Pérez JH, Sánchez-Aguilar M, Della Vecchia RR, Chalita Williams JC, Cerda-Gutiérrez R. Comparison of cerebrospinal fluid obtained by ventricular endoscopy and by lumbar puncture in patients with hydrocephalus secondary to neurocysticercosis. Surg Neurol 2009;71:376-379.

  11. Suástegui R, Gutiérrez J, Ramos R, Bouchan S, Navarrete H, Ruiz J, et al. Clinical characteristics of the late-onset epilepsy in Mexico to the beginning of the new millennium: 455 cases. Rev Invest Clin 2009;61:354-363.

  12. Fleury A, Moreno-García J, Valdez-Aguerrebere P, de Sayve-Durán M, Becerril-Rodríguez P, Larralde C, et al. Neurocysticercosis, a persisting health problem in Mexico. PLoSNegl Trop Dis 2010;4:e805.

  13. Cardenas G, Bahena A, Soto-Hernandez JL, Fleury A. A dramatic case of intraventricular cysticercosis. Arch Neurol 2011;68:828-829.

  14. Cárdenas G, Valdez R, Sáenz B, Bottasso O, Fragoso G, Sciutto E, et al. Impact of Taenia solium neurocysticercosis upon endocrine status and its relation with immuno-inflammatory parameters. Int J Parasitol 2012;42:171-176.

  15. Fleury A, Gómez T, Alvarez I, Meza D, Huerta M, Chavarria A, et al. High prevalence of calcified silent neurocysticercosis in a rural village of Mexico. Neuroepidemiology 2003;22:139-145.

  16. Fleury A, Morales J, Bobes RJ, Dumas M, Yánez O, Piña J, et al. An Epidemiological study of familial neurocysticercosis in an endemic Mexican community. Trans R Soc Trop Med Hyg 2006;100: 551-558.

  17. Morales J, Velasco T, Tovar V, Fragoso G, Fleury A, Beltrán C, et al. Castration and pregnancy of rural pigs significantly increase the prevalence of naturally acquired Taenia solium cysticercosis. Vet Parasitol 2002;108:41-48.

  18. Morales J, Martínez JJ, García-Castella J, Peña N, Maza V, Villalobos N, et al. Taenia solium: the complex interactions of biological, social, geographical and commercial factors, involved in the transmission dynamics of pig cysticercosis in highly endemic areas. Ann Trop Med Parasitol 2006;100:123-135.

  19. Morales J, Martínez JJ, Manoutcharian K, Hernández M, Fleury A, Gevorkian G, et al. Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis. Vaccine 2008;26: 2899-2905.

  20. Stevens G, Dias RH, Thomas KJ, Rivera JA, Carvalho N, Barquera S, et al. Characterizing the epidemiological transition in Mexico: national and subnational burden of diseases, injuries, and risk factors. PLoS Med 2008;5:e125.

  21. Flisser A, Correa D. Neurocysticercosis may no longer be a public health problem in Mexico. PLoS Negl Trop Dis 2010;4: e831.

  22. Secretaría de Salud. Modificación a la Norma Oficial Mexicana NOM- 021-SSA2-1994, para la prevención y control del complejo teniosis/ cisticercosis en el primer nivel de atención médica. Diario Oficial de la Federación, 2004. [consultado 2011 agosto]. Disponible en: http://www. salud.gob.mx/unidades/cdi/nom/m021ssa294.html.

  23. Winslow CE A. The Untilled Fields of Public Health.Science 1920;51:23.

  24. Fleury A, Carrillo-Mezo R, Flisser A, Sciutto E, Corona T. Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti infect Ther 2011;9:123-133.

  25. Bhattarai R, Budke CM, Carabin H, Proaño JV, Flores-Rivera J, Corona T, et al. Quality of Life in Patients with Neurocysticercosis in Mexico. Am J Trop Med Hyg 2011;84:782-786.

  26. Del Brutto OH, Roos KL, Coffey CS, García HH. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 2006;145:43-51.

  27. Assana E, Kyngdon CT, Gauci CG, Geerts S, Dorny P, De Deken R, et al. Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon. Int J Parasitol 2010;40:515-519.

  28. Cai X, Yuan G, Zheng Y, Luo X, Zhang S, Ding J, et al. Effective production and purification of the glycosylated TSOL18 antigen, which is protective against pig cysticercosis. Infect Immun 2008;76:767-770.

  29. Jung H, Cárdenas G, Sciutto E, Fleury A. Medical Treatment for Neurocysticercosis: Drugs, Indications and Perspectives. Curr Top Med Chem 2008;8:424-433.

  30. Sorvillo F, Wilkins P, Shafir S, Eberhard M. Public Health Implications of Cysticercosis Acquired in The United States. Emerg Infect Dis 2011;17:1-6.

  31. Morales J, De Aluja A, Martinez JJ, Hernandez M, Rosas G, Villalobos N, et al. Recombinant S3Pvac-phage anticysticercosis vaccine; Simultaneous protection against cysticercosis and hydatid disease in rural pigs. Vet Parasitol 2011;176: 53-58.

  32. World Health Organization. WHO Expert Consultation on Foodborne Trematode Infections and Taeniasis/Cysticercosis. 2011, Geneva, Switzerland: WHO, 2011: 59.

  33. Instituto Nacional de Estadística y Geografía. Encuesta Nacional de Ingresos y Gastos de los Hogares (ENIGH). 2008 [consultado 2011 agosto]. Disponible en: http://www.inegi.org.mx




2020     |     www.medigraphic.com